病例报告:组织细胞肉瘤为边缘区淋巴瘤的转分化-基于尸检和文献回顾的病例报告。

IF 3.5 3区 医学 Q2 ONCOLOGY
Frontiers in Oncology Pub Date : 2025-09-17 eCollection Date: 2025-01-01 DOI:10.3389/fonc.2025.1609694
Annaïse J Jauch, Ilaria Alborelli, Ilaria Balestri, Fatime Krasniqi, Alexandar Tzankov, Benjamin Kasenda, Thomas Menter
{"title":"病例报告:组织细胞肉瘤为边缘区淋巴瘤的转分化-基于尸检和文献回顾的病例报告。","authors":"Annaïse J Jauch, Ilaria Alborelli, Ilaria Balestri, Fatime Krasniqi, Alexandar Tzankov, Benjamin Kasenda, Thomas Menter","doi":"10.3389/fonc.2025.1609694","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Histiocytic sarcoma (HS) is a rare and aggressive hematopoietic malignancy characterized by the proliferation of cells resembling mature histiocytes. It typically presents in extranodal sites such as the skin, the gastrointestinal tract, and soft tissues and is often accompanied by systemic symptoms including fever and weight loss. HS occurs <i>de novo</i> or results from transformation/transdifferentiation from other hematological neoplasms, such as low-grade B-cell lymphomas. To date, only four cases of HS arising from marginal zone lymphomas (MZL) have been documented.</p><p><strong>Case presentation: </strong>We describe a 66-year-old female patient who presented primarily with abdominal pain and constitutional symptoms. The clinical evaluation showed significant hepatosplenomegaly and lymphadenopathy. A liver biopsy demonstrated a sinus-associated spread of HS. The patient died of suspected hemorrhagic shock before the diagnostic results were finalized and before rescue treatment could be initiated. The autopsy findings confirmed a widespread metastatic HS and concurrent MZL. The molecular analysis showed that both neoplasmas were clonally related, supporting the hypothesis of transformation/transdifferentiation of MZL into HS.</p><p><strong>Conclusion: </strong>We have reported the fifth unusual transformation of a MZL into a HS. Transformed/transdifferentiated HS is a rare and aggressive neoplasm. Evidence from the published case reports suggests that its clinical course may be more severe than <i>de novo</i> HS. This underscores the importance of investigating rare presentations and considering the possibility of an underlying pre-existing hematological malignancy.</p>","PeriodicalId":12482,"journal":{"name":"Frontiers in Oncology","volume":"15 ","pages":"1609694"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12483895/pdf/","citationCount":"0","resultStr":"{\"title\":\"Case report: Histiocytic sarcoma as transdifferentiation of a marginal zone lymphoma-a case presentation based on <i>post mortem</i> examination and review of the literature.\",\"authors\":\"Annaïse J Jauch, Ilaria Alborelli, Ilaria Balestri, Fatime Krasniqi, Alexandar Tzankov, Benjamin Kasenda, Thomas Menter\",\"doi\":\"10.3389/fonc.2025.1609694\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Histiocytic sarcoma (HS) is a rare and aggressive hematopoietic malignancy characterized by the proliferation of cells resembling mature histiocytes. It typically presents in extranodal sites such as the skin, the gastrointestinal tract, and soft tissues and is often accompanied by systemic symptoms including fever and weight loss. HS occurs <i>de novo</i> or results from transformation/transdifferentiation from other hematological neoplasms, such as low-grade B-cell lymphomas. To date, only four cases of HS arising from marginal zone lymphomas (MZL) have been documented.</p><p><strong>Case presentation: </strong>We describe a 66-year-old female patient who presented primarily with abdominal pain and constitutional symptoms. The clinical evaluation showed significant hepatosplenomegaly and lymphadenopathy. A liver biopsy demonstrated a sinus-associated spread of HS. The patient died of suspected hemorrhagic shock before the diagnostic results were finalized and before rescue treatment could be initiated. The autopsy findings confirmed a widespread metastatic HS and concurrent MZL. The molecular analysis showed that both neoplasmas were clonally related, supporting the hypothesis of transformation/transdifferentiation of MZL into HS.</p><p><strong>Conclusion: </strong>We have reported the fifth unusual transformation of a MZL into a HS. Transformed/transdifferentiated HS is a rare and aggressive neoplasm. Evidence from the published case reports suggests that its clinical course may be more severe than <i>de novo</i> HS. This underscores the importance of investigating rare presentations and considering the possibility of an underlying pre-existing hematological malignancy.</p>\",\"PeriodicalId\":12482,\"journal\":{\"name\":\"Frontiers in Oncology\",\"volume\":\"15 \",\"pages\":\"1609694\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12483895/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fonc.2025.1609694\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fonc.2025.1609694","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:组织细胞肉瘤(HS)是一种罕见的侵袭性造血恶性肿瘤,其特征是类似于成熟组织细胞的细胞增殖。它通常出现在结外部位,如皮肤、胃肠道和软组织,并常伴有全身症状,包括发烧和体重减轻。HS可由其他血液肿瘤(如低级别b细胞淋巴瘤)的转化/转分化引起。迄今为止,只有4例HS引起的边缘区淋巴瘤(MZL)已被记录。病例介绍:我们描述了一位66岁的女性患者,主要表现为腹痛和体质症状。临床表现为肝脾肿大及淋巴结肿大。肝活检显示肝窦相关扩散。在诊断结果最终确定和开始抢救治疗之前,患者死于疑似失血性休克。尸检结果证实了广泛的转移性HS和并发MZL。分子分析表明两种肿瘤具有克隆相关性,支持MZL向HS转化/转分化的假设。结论:我们报道了第五例罕见的MZL向HS的转变。转化/转分化HS是一种罕见的侵袭性肿瘤。来自已发表病例报告的证据表明,其临床病程可能比新发HS更严重。这强调了调查罕见的表现和考虑潜在的预先存在的血液恶性肿瘤的可能性的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Case report: Histiocytic sarcoma as transdifferentiation of a marginal zone lymphoma-a case presentation based on post mortem examination and review of the literature.

Background: Histiocytic sarcoma (HS) is a rare and aggressive hematopoietic malignancy characterized by the proliferation of cells resembling mature histiocytes. It typically presents in extranodal sites such as the skin, the gastrointestinal tract, and soft tissues and is often accompanied by systemic symptoms including fever and weight loss. HS occurs de novo or results from transformation/transdifferentiation from other hematological neoplasms, such as low-grade B-cell lymphomas. To date, only four cases of HS arising from marginal zone lymphomas (MZL) have been documented.

Case presentation: We describe a 66-year-old female patient who presented primarily with abdominal pain and constitutional symptoms. The clinical evaluation showed significant hepatosplenomegaly and lymphadenopathy. A liver biopsy demonstrated a sinus-associated spread of HS. The patient died of suspected hemorrhagic shock before the diagnostic results were finalized and before rescue treatment could be initiated. The autopsy findings confirmed a widespread metastatic HS and concurrent MZL. The molecular analysis showed that both neoplasmas were clonally related, supporting the hypothesis of transformation/transdifferentiation of MZL into HS.

Conclusion: We have reported the fifth unusual transformation of a MZL into a HS. Transformed/transdifferentiated HS is a rare and aggressive neoplasm. Evidence from the published case reports suggests that its clinical course may be more severe than de novo HS. This underscores the importance of investigating rare presentations and considering the possibility of an underlying pre-existing hematological malignancy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Oncology
Frontiers in Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
6.20
自引率
10.60%
发文量
6641
审稿时长
14 weeks
期刊介绍: Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信